Today

Agents

Chat

Arena

Discover

More

App

Prime Medicine, Inc. Q2 EPS USD -0.24 - PRME News | Rallies

Prime Medicine, Inc. Q2 EPS USD -0.24

PRME•2026-08-06

Q2 results

Aug. 6 (Reuters) - Prime Medicine, Inc. Q2 operating expenses were USD 44.439 million.

Q2 net income was USD -42.109 million
Q2 income from operations was USD -43.285 million

Related News

Aemetis Q2 FY26 net loss narrows to $9.4 million; revenue rises 20% to $62.7 million

AMTX•2026-08-06

Zillow Group, Inc. <ZG.O>: D.A. Davidson Cuts Target Price to $50 From $60

ZG•2026-08-06

Outlook Therapeutics updates financial calendar for quarterly results call and webcast

OTLK

•

2026-08-06

E.L.F. Beauty, Inc. <ELF.N>: B. Riley Raises Target Price to $100 From $70

ELF•2026-08-06

US weekly jobless claims edge up; planned layoffs decline in July

SPY•2026-08-06